Diagnosis, prognosis, and treatment of impaired glucose tolerance and impaired fasting glucose.

P L, Santaguida; C, Balion; D, Hunt; K, Morrison; H, Gerstein; P, Raina; L, Booker; H, Yazdi

Found an issue? Give us feedback

https://pubmed.ncbi....arrow_drop_down

https://pubmed.ncbi.nlm.nih.go...

Article . 2005

Data sources: Europe PubMed Central

Diagnosis, prognosis, and treatment of impaired glucose tolerance and impaired fasting glucose.

descriptionPublicationkeyboard_double_arrow_right Article 28 Oct 2005 English Journal:Evidence report/technology assessment (Summary) (issn: 1530-440X,

Copyright policy )

Authors: P L, Santaguida; C, Balion; D, Hunt; K, Morrison; H, Gerstein; P, Raina; L, Booker; +1 Authors

pmid: 16194123

pmc: PMC4780988

Diagnosis, prognosis, and treatment of impaired glucose tolerance and impaired fasting glucose.

- Summary
- Subjects
- Metrics

No summary information available

Keywords

Adult, Blood Glucose, Cardiovascular Diseases, Glucose Intolerance, Diabetes Mellitus, Humans, Hypoglycemic Agents, Glucose Tolerance Test, Child, Prognosis

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	91
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Top 10%
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Top 1%
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Top 10%